D.16 If task/delivery over SAT and FAR exception to fair opportunity is 16.505(b)(2)(ii)(D) used, has posting requirement been properly followed? D.17 If task/delivery order over $5M under FAR IDIQ, does requirement sent under 16.505(a)(9)(b)(iii) fair opportunity provide proper information? D.18 If task/delivery order over $5M under FAR 16.505(b)(4) IDIQ, has CO properly notified unsuccessful offerors? D.19 If task or delivery order over FAR 45.1502 simplified acquisition threshold is against a contract awarded by another Federal agency (i.e., GWAC or MAC), has past performance evaluation been performed? No. Action Item FAR/HHSAR/ Yes No N/A Comments NIH Policy Part D.20 As applicable, has CO bilaterally FAR 3.1103, modified task order 3.1104, 3.1105, contract to include FAR 52.203-16 3.1106; 52.203-16 regarding conflicts of interest? D.21 If IDIQ contract and remaining FAR 22.1803, period of performance extends 52.222-54, CAAC beyond 3/8/2010, and amount of Letter 2009-03, work or number of orders expected dated 9/3/09 under remaining performance period is substantial, has bilateral
D.16 If task/delivery over SAT and exception to fair opportunity is used, has posting requirement been properly followed? FAR 16.505(b)(2)(ii)(D) D.17 If task/delivery order over $5M under IDIQ, does requirement sent under fair opportunity provide proper information? FAR 16.505(a)(9)(b)(iii) D.18 If task/delivery order over $5M under IDIQ, has CO properly notified unsuccessful offerors? FAR 16.505(b)(4) D.19 If task or delivery order over simplified acquisition threshold is against a contract awarded by another Federal agency (i.e., GWAC or MAC), has past performance evaluation been performed? FAR 45.1502 No. Action Item FAR/HHSAR/ NIH Policy Part Yes No N/A Comments D.20 As applicable, has CO bilaterally modified task order contract to include FAR 52.203-16 regarding conflicts of interest? FAR 3.1103, 3.1104, 3.1105, 3.1106; 52.203-16 D.21 If IDIQ contract and remaining period of performance extends beyond 3/8/2010, and amount of work or number of orders expected under remaining performance period is substantial, has bilateral FAR 22.1803, 52.222-54, CAAC Letter 2009-03, dated 9/3/09